JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, cilt.67, sa.6, ss.538-543, 2016 (SCI-Expanded)
Purpose: Hypertension is a risk factor for cognitive impairment (CI). However, the specific effect of antihypertensive therapy on cognitive function is still controversial. We aimed to investigate the effect of antihypertensive agents targeting the renin-angiotensin system (RAS) on CI and brain-derived neurotropic factor (BDNF).